Atlas Trials

A Long Term Safety Study of Degarelix in Patients With Prostate Cancer

Clinical trial NCT00967018 · COMPLETED

Trial details

NCT number
NCT00967018
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2009-08-01
Primary completion
2011-11-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.